Literature DB >> 1810811

The long-term treatment with the Ca(2+)-antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine decreases the activity of 5-HT1 receptors in rat cerebral cortex and hippocampus.

J Popova1, D Staneva-Stoytcheva, E Ivanova, T Tosheva.   

Abstract

1. The binding activity of 5-HT1 receptors was studied in membrane fractions from the cerebral cortex and hippocampus of male Wistar rats treated orally for 13 days with the Ca(2+)-antagonists nifedipine (20 mg/kg), verapamil (50 mg/kg) and flunarizine (10 mg/kg) and with the calmodulin antagonist trifluoperazine (3 mg/kg). 2. The binding capacity and affinity of the 5-HT1 receptors in the cerebral cortex were significantly decreased after the treatment with the Ca(2+)-antagonists nifedipine, verapamil and flunarizine. The dissociation constant (Kd) was increased after the treatment with the calmodulin antagonist trifluoperazine. 3. In the hippocampus the 5-HT1 receptor affinity and number of binding sites were significantly reduced after the treatment with all four antagonists tested--nifedipine, verapamil, flunarizine and trifluoperazine, the Kd value being increased insignificantly after the flunarizine treatment. 4. The results obtained afford the suggestion that the reduction of 5-HT1 receptor activity is at least one of the results of the well known Ca(2+)-ions mediated automodulation of 5-HT release. The data confirm the view about the great importance of Ca(2+)-ions for the regulation of membrane neurotransmitter receptor activities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1810811     DOI: 10.1016/0306-3623(91)90593-u

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  2 in total

1.  Verapamil Blocks Scopolamine Enhancement Effect on Memory Consolidation in Passive Avoidance Task in Rats.

Authors:  Verónica Giménez De Béjar; María Caballero Bleda; Natalija Popović; Miroljub Popović
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

Review 2.  Verapamil and Alzheimer's Disease: Past, Present, and Future.

Authors:  Natalija Popović; Nicanor Morales-Delgado; David Vidal Mena; Antonia Alonso; María Pascual Martínez; María Caballero Bleda; Miroljub Popović
Journal:  Front Pharmacol       Date:  2020-05-05       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.